These effects, together with a earlier report exhibiting that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,two help the strategy of targeting ACKR3 as a singular strategy to modulate the opioid technique, which could open up new therapeutic avenues for opioid-r